BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

GlaxoSmithKline (GSK) Targets "Electroceuticals" for Potential New Therapies


4/11/2013 7:42:28 AM

Drug discovery typically was initially a chemistry endeavor. Biological drugs, made from biological processes, was the next breakthrough. GlaxoSmithKline (NYSE: GSK) wants to see new treatments can be found in yet another way – by targeting electrical signals in the body. To encourage the effort, the company said on Wednesday it is offering a $1 million prize and funding up to 40 researchers working in external laboratories. GSK unveiled the initiative in the journal Nature. "At GlaxoSmithKline and in academia, we are confident that this field will deliver real medicines, and we are mobilising resources for this journey," GSK head of bioelectronics research Kristoffer Famm and colleagues wrote in the journal. This emerging "electroceuticals" field has also grabbed the attention of a number of academic research groups which are already mapping neural circuits in animals and humans, and working on potential interventions for testing in clinical trials.

Read at WRAL.com
Read at Reuters
Read at News Release
Read at News Release
Read at Pharma Times [Free Reg Req'd]

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->